
High-end Medical Device R&D and Manufacturer
MicroPortAnnouncement: The Company is considering appointing one or more placing agents for the proposed placing, pursuant to which a certain number of new ordinary shares to be issued by the Company may be placed under the general mandate granted by the shareholders of the Company, with an expected fundraising of approximately HK$200 million.US Dollar。
MicroPort (00853.HK) is a leading high-end medical device group in China, with products covering cardiovascular intervention, heart rate management, orthopedic implants and repair, aortic and peripheral vascular intervention, electrophysiology, neurointerventional procedures, and other business segments.